https://www.sitala.com/home daily 1.0 2025-01-02 https://images.squarespace-cdn.com/content/v1/607ed89c9bc73d41f377bc01/1621000146717-XD3OE9PFLDDMA5RYY0QQ/unsplash-image--p_HZ1et98U.jpg Home Our immune systems evolved to deal with infections, which were a leading cause of illness and death. As we now live much longer, our immune systems begin to trigger chronic, low-grade inflammation. This then drives inflammatory diseases in the brain and body. https://images.squarespace-cdn.com/content/v1/607ed89c9bc73d41f377bc01/74bcec25-7f0d-42ab-80cf-6a4cf2e11855/CNS+2.jpg Home Evidence supports a pivotal role for chronic inflammation in the advent and progression of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Dysfunction of immune cells such as microglia and astrocytes in the brain leads to the production of inflammatory molecules, which prevent clearance of toxins, such as amyloid, from the brain. https://images.squarespace-cdn.com/content/v1/607ed89c9bc73d41f377bc01/3f6f5943-150e-4fa3-8639-d1cbf9cdd10b/767114428-huge.jpg Home Systemic inflammation in the body can lead to musco-skeletal, lung, kidney, gut, skin, eye and other diseases. By blocking the initiation and progression of harmful inflammation in these conditions, we aim to treat both the symptoms and the underlying cause of illnesses that affect many people.